1
|
Guinde J, Laroumagne S, Kaspi E, Martinez S, Tazi-Mezalek R, Astoul P, Dutau H. [Endobronchial ultrasound in the diagnosis of malignant pleural mesothelioma]. Rev Mal Respir 2015; 32:750-4. [PMID: 26071130 DOI: 10.1016/j.rmr.2014.12.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2014] [Accepted: 12/29/2014] [Indexed: 11/29/2022]
Abstract
The diagnosis of malignant pleural mesothelioma relies mostly on the pathological examination of pleural samples, validated by a panel of experts and generally obtained during medical or surgical thoracoscopy performed for the management of an exudative pleural effusion. In the absence of pleural effusion (dry-type mesothelioma), the diagnostic approach depends on the features of the lesions (pleural thickness, nodules and/or masses) and their pleural location. Ultrasound and CT-guided needle aspiration represent recognized alternative diagnostic techniques in these situations. We present the case of a patient, presenting a dry-type mesothelioma, whose diagnosis was obtained by endobronchial ultrasound (EBUS)-guided needle aspiration of a pleural mediastinal mass and confirmed by a CT-guided needle aspiration of another pleural mass in close contact with the chest wall. The samples have been compared and show quantitative and qualitative similarities. EBUS represents a minimally invasive alternative diagnostic technique for dry-type mesothelioma, showing thickness of the mediastinal pleura in contact with a central airway or when thoracoscopy, which remains the "gold standard" diagnostic approach, is not feasible.
Collapse
Affiliation(s)
- J Guinde
- Service d'oncologie thoracique, maladie de la plèvre et pneumologie interventionnelle, hôpital Nord, chemin des Bourrely, 13000 Marseille, France
| | - S Laroumagne
- Service d'oncologie thoracique, maladie de la plèvre et pneumologie interventionnelle, hôpital Nord, chemin des Bourrely, 13000 Marseille, France
| | - E Kaspi
- Service de biologie cellulaire, hôpital La Timone, 13000 Marseille, France; Université d'Aix-Marseille, 13000 Marseille, France
| | - S Martinez
- Service d'oncologie thoracique, maladie de la plèvre et pneumologie interventionnelle, hôpital Nord, chemin des Bourrely, 13000 Marseille, France
| | - R Tazi-Mezalek
- Service d'oncologie thoracique, maladie de la plèvre et pneumologie interventionnelle, hôpital Nord, chemin des Bourrely, 13000 Marseille, France
| | - P Astoul
- Service d'oncologie thoracique, maladie de la plèvre et pneumologie interventionnelle, hôpital Nord, chemin des Bourrely, 13000 Marseille, France; Université d'Aix-Marseille, 13000 Marseille, France
| | - H Dutau
- Service d'oncologie thoracique, maladie de la plèvre et pneumologie interventionnelle, hôpital Nord, chemin des Bourrely, 13000 Marseille, France.
| |
Collapse
|